Evodiamine as a novel antagonist of aryl hydrocarbon receptor
Biochem Biophys Res Commun 402(1):5 (2010) PMID 20888792
Evodiamine, the major bioactive alkaloid isolated from Wu-Chu-Yu, has been shown to interact with a wide variety of proteins and modify their expression and activities. In this study, we investigated the interaction between evodiamine and the aryl hydrocarbon receptor (AhR). Molecular modeling results revealed that evodiamine directly interacted with the AhR. Cytosolic receptor binding assay also provided the evidence that evodiamine could interact with the AhR with the K"i value of 28.4+/-4.9nM. In addition, we observed that evodiamine suppressed the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced nuclear translocation of the AhR and the expression of CYP1A1 dose-dependently. These results suggested that evodiamine was able to bind to the AhR as ligand and exhibit antagonistic effects.
Copyright © 2010 Elsevier Ltd. All rights reserved.
DOI: 10.1016/j.bbrc.2010.09.122
Version: za2963e q8za1 q8zbb q8zcb q8zd2 q8zec q8zfd q8zgd